Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
Sun Pharma→Organon
May 1, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
PharmaCorp Rx has acquired PharmaChoice Canada pharmacies, a pharmacy business in Canada, for $24.2 million. PharmaChoice Canada operates pharmacist-led community pharmacy locations, and PharmaCorp Rx acquisitions expand its healthcare M&A footprint in Eastern Canada while preserving local managing pharmacists. The pharmacy acquisition adds eight bannered stores, increasing PharmaCorp Rx’s presence from six to fourteen locations and strengthening market density in major urban areas plus rural communities. The strategic acquisition is structured as an add on acquisition by a strategic buyer, with PharmaCorp Rx Rx planning integration of the acquired locations and funding the purchase from existing cash resources; additional letters of intent cover four more potential pharmacy acquisition targets.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
May 1, 2026
Vireo Growth→Fluent
May 1, 2026
United Surgical Partners International→ASCs (seven acquired)
Apr 30, 2026
Volaris Group→Interplayers
Apr 30, 2026
Tenet Healthcare→United Surgical Partners International
Apr 30, 2026